Manidipine hydrochloride-induced chyloperitoneum in a patient with systemic lupus erythematosus.
Tanabe
M
M
Iwata
H
H
Kinoshita
M
M
Sumiya
M
M
Saima
S
S
D000328:Adult; D002121:Calcium Channel Blockers / Q000009:adverse effects* / Q000627:therapeutic use; D002915:Chylous Ascites / Q000139:chemically induced*; D004095:Dihydropyridines / Q000009:adverse effects* / Q000627:therapeutic use; D005260:Female; D006801:Humans; D006973:Hypertension / Q000188:drug therapy / Q000209:etiology; D008180:Lupus Erythematosus, Systemic / Q000150:complications* / Q000188:drug therapy; D009578:Nitrobenzenes; D010879:Piperazines
D002121:Calcium Channel Blockers; D004095:Dihydropyridines; D009578:Nitrobenzenes; D010879:Piperazines; C054218:manidipine